| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $233.3M | -16.2% |
| R&D Expense | $39.8M | -19.8% |
| SG&A Expense | $47.3M | -16.3% |
| Operating Income | -$101.8M | +47.9% |
| Pre-tax Income | -$103.5M | +45.3% |
| Income Tax | $0 | — |
| Net Income | -$103.5M | +45.3% |
| EPS (Basic) | -$1.95 | +50.1% |
| EPS (Diluted) | -$1.95 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.7M | -25.7% |
| Accounts Receivable | $82.7M | -19.9% |
| Current Assets | $137.3M | -22.9% |
| Total Assets | $285.6M | -27.3% |
| Current Liabilities | $78.4M | -47.4% |
| Long-term Debt | $212.6M | -2.7% |
| Total Liabilities | $292.1M | -9.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.3M | +205.3% |
| Capital Expenditures | $480K | -69.3% |
| Investing Cash Flow | -$15.3M | +18.4% |
| Financing Cash Flow | -$11.1M | -870.2% |
| Free Cash Flow | $8.8M | +184.8% |
| +50.1% |
| Stockholders' Equity |
| -$6.5M |
| -109.3% |